Hi Israel and Thomas,
Please be careful when you share links like this.... If you go through the comments on the 'letsrun' forum - the second link you provided - you will see this following comment about the guy that published this 'article'
"He's not a doctor. He's a cryptocurrency promoter who read a single medical article and thinks that makes him an expert on an incredibly complicated novel viral pathogen that the collective medical community worldwide is struggling to understand."
That is not to say that some doctors who have been treating COVID-19 patients have not questioned how it is being treated and postulated that they may be treating it in an ineffective way. The particular NYC Dr. that postulated this also said that he was not saying that ventilators should not be used at all, he was asking for input from other ICU/emergency care doctors about how to treat this virus more effectively. I have mentioned him in another thread.
As for the idea that because dasatinib (or other TKIs) suppress red blood cells they therefore put people more at risk from developing serious complications from this virus.... this is not backed up by any significant real world data proving causation. CML expert clinicians have answered this question very clearly... "this is theoretical at best" and available data do not support dasatinib increases the risk of serious events from COVID-19 infection.
If you have your recent blood result to hand take a look at your HGb levels and compare them to 'normal' levels. Complications arising from contracting this virus seem follow an unusual path, but people treated with TKI therapies are thought to be at no greater risk than the 'normal' population.
If you are over a certain age profile and/or are physically not fit and/or have a co-morbidity such as cardio vascular disease/diabetes etc then your risk increases with each of these cohorts - TKI therapy not withstanding.